Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America

International Journal of Antimicrobial Agents

Volumn 34, Issue 4, 2009, Pages 304-308

  Guzmán Blanco, Manuel ^a   Mejía, Carlos ^b   Isturiz, Raul ^a   Alvarez, Carlos ^c   Bavestrello, Luis ^d   Gotuzzo, Eduardo ^e   Labarca, Jaime ^f   Luna, Carlos M ^g   Rodríguez Noriega, Eduardo ^h   Salles, Mauro J C ⁱ   Zurita, Jeannete ^j   Seas, Carlos ^e  

^a Centro Medico Docente La Trinidad   (Venezuela)

^b Roosevelt Hospital Guatemala   (Guatemala)

^c PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^d Unidad de Cuidados Intensivos   (Chile)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^g UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^h HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

ⁱ IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

^j HOSPITAL VOZANDES   (Ecuador)

more..

Author keywords

Epidemiology; Latin America; Meticillin resistant Staphylococcus aureus; Surveillance

Indexed keywords

CEFOXITIN; COTRIMOXAZOLE; LINEZOLID; METICILLIN; OXACILLIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BIBLIOGRAPHIC DATABASE; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFORMATION PROCESSING; INTERNET; MEDICAL LITERATURE; MEDLINE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SKIN INFECTION; SOUTH AND CENTRAL AMERICA; UNITED STATES; COMMUNICABLE DISEASE; CROSS INFECTION; MICROBIOLOGY; REVIEW; STAPHYLOCOCCUS INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; LATIN AMERICA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS;

EID: 67849100867     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.06.005     Document Type: Short Survey

References (36)

1. Ayliffe G.A. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 24 Suppl. 1 (1997) S74-S79
2. Klevens R.M., Edwards J.R., Tenover F.C., McDonald L.C., Horan T., and Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 42 (2006) 389-391
3. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
4. EARSS Annual Report 2006. http://www.rivm.nl/earss/Images/EARSS%202006%20Def_tcm61-44176.pdf [accessed 8 July 2008].
5. Shorr A.F. Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature. Pharmacoeconomics 25 (2007) 751-768
6. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
7. Jevons M.P. 'Celbenin'-resistant staphylococci. Br Med J i (1961) 124-125
8. Turnidge J.D., and Bell J.M. Methicillin-resistant Staphylococcal aureus evolution in Australia over 35 years. Microb Drug Resist 6 (2000) 223-229
9. Maltezou H.C., and Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents 27 (2006) 87-96
10. Zetola N., Francis J.S., Nuermberger E.L., and Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5 (2005) 275-286
11. Gorwitz R.J. Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community. J Infect Dis 197 (2008) 179-182
12. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13 (2007) 1510-1514
13. McDougal L.K., Steward C.D., Killgore G.E., Chaitram J.M., McAllister S.K., and Tenover F.C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41 (2003) 5113-5120
14. Mulvey M.R., MacDougall L., Cholin B., Horsman G., Fidyk M., and Woods S. Community-associated methicillin-resistant Staphylococcus aureus. Canada. Emerg Infect Dis 11 (2005) 844-850
15. Pan American Health Organization. Annual report of the Monitoring/Surveillance Network for Resistance to Antibiotics, 2004. Publicación Organización Panamericana de la Salud OPS/HDM/CD/A/408/6. http://www.paho.org/English/AD/DPC/CD/amr-2004.htm [accessed 9 July 2008].
16. Casellas J.M., and Comité Resistencia Antibacterianos API. Results survey number 7. Revista Panamericana de Infectología 8 (2006) 48-51
17. Loureiro M.M., Graces B., Quadra M., Pinheiro G.S., and Asensi M.D. Study of multi-drug resistant microorganisms isolated from blood cultures of hospitalized newborns in Rio de Janeiro city, Brazil. Braz J Microbiol 33 (2002) 73-78
18. Lisboa T., Faria M., Hoher J.A., Borges L.A.A., Gómez J., Schifelbain L., et al. The prevalence of nosocomial infection in Intensive Care Units in the State of Rio Grande do Sul. Rev Bras Ter Intensiva 19 (2007) 414-420
19. Seas C., Hernandez K., Ramos R., Bazan E., Rodriguez I., Torres A., et al. Oxacillin-resistant and multidrug-resistant Staphylococcus aureus in Lima, Peru. Infect Control Hosp Epidemiol 27 (2006) 198-200
20. Ponce de Leon A., Amabile-Cuevas C.F., and Benitez A. In vitro activity of tigecycline and other antimicrobial drugs against selected pathogens isolated in Mexico. Clin Microbiol Infect 14 Suppl 7 (2008) S611 Abstract P2075
21. Buitrago G., Cortes J.A., Castillo J.S., Leal A.L., Sanchez R., and Alvarez C.A. Methicillin-resistant Staphylococcus aureus. Community-acquired phenotype spread in hospitals in Bogota, Colombia. Clin Microbiol Infect 14 Suppl. 7 (2008) S411 Abstract P1438
22. Otth R.L., Wilson S.M., Bustamante H.N., Fernández J.H., and Otth L.C. Antimicrobial susceptibility and resistance patterns of Staphylococcus aureus isolated from patients and carriers in Valdivia city, Chile. Rev Chilena Infectol 25 (2008) 175-178
23. Provenra.org. Venezuelan program of surveillance of bacterial resistance to antibiotics; 1998-2006. http://www.provenra.org [accessed 9 July 2008].
24. Picao R., Sader H., Jones R., Andrade S., and Gales A. Analysis of resistance and vancomycin 'reverse creep' in Latin American Staphylococcus aureus: ten-year report of the SENTRY Antimicrobial Surveillance Program (1997-2006). Clin Microbiol Infect 14 Suppl. 7 (2008) S173 Abstract P688
25. Melo G., Melo M.C., Gama A.P., Carvalho K.S., Jesus T.C., Bonetti A.M., et al. Analysis of the genetic diversity of vancomycin-resistant Staphylococcus aureus. Braz J Microbiol 36 (2005) 126-130
26. Lescure F.X., Locher G., Eveillard M., and Biendo M. Van Agt S, Le Loup G, et al. Community-acquired infection with healthcare-associated methicillin-resistant Staphylococcus aureus: the role of home nursing care. Infect Control Hosp Epidemiol 27 (2006) 1213-1218
27. Robinson D.A., and Enright M.C. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47 (2003) 3926-3934
28. Flynn N., and Cohen S.H. The continuing saga of MRSA. J Infect Dis 197 (2008) 1217-1219
29. David M.Z., Glikman D., Crawford S.E., Peng J., King K.J., Hostetler M.A., et al. What is community-associated methicillin-resistant Staphylococcus aureus?. J Infect Dis 197 (2008) 1235-1243
30. Ribeiro A., Dias C., Silva-Carvalho M.C., Berquo L., Ferreira F.A., Santos R.N., et al. First report of infection with community-acquired methicillin-resistant Staphylococcus aureus in South America. J Clin Microbiol 43 (2005) 1985-1988
31. Ma X.X., Galiana A., Pedreira W., Mowszowicz M., Christophersen I., Machiavello S., et al. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis 11 (2005) 973-976
32. Mowszowicz M., Pedreira W., Galiana A., Hiramatsu K., Ma X.X., Ito T., et al. Efficacy of co-trimoxazole-high dosage short course (SXT-HDSC) in community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) outbreak in Uruguay jails 2003. Int J Infect Dis 8 Suppl. 1 (2004) 185
33. Alvarez C.A., Barrientes O.J., Leal A.L., Contreras G.A., Barrero L., Rincon S., et al. Community-associated methicillin-resistant Staphylococcus aureus, Colombia. Emerg Infect Dis 12 (2006) 2000-2001
34. Aylwin M, Serri M, Gracía P, Sader H, Perez C. Staphylococcus aureus meticilino resistente asociado a la comunidad en Chile. In: XXIV Chilean Conference of Infectious Diseases; November 2007; Pucón, Chile. Abstract.
35. Noriega L.M., González P., Hormazábal J.C., Pinto C., Canals M., Munita J.M., et al. Community-acquired infections with methicillin-resistant strains of Staphylococcus aureus: report of five cases [in Spanish]. Rev Med Chil 136 (2008) 885-891
36. Lodise T.P., McKinnon P.S., Swiderski L., and Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36 (2003) 1418-1423